Low-renin hypertension of childhood

J DiMartino-Nardi1, M I New

  • 1Department of Pediatrics, New York Hospital-Cornell Medical Center, NY 10021.

Insights

Diagnosing childhood hypertension requires measuring plasma renin activity (PRA) and aldosterone levels, considering sodium intake. Understanding steroid production is key to treating low-renin hypertension and preventing irreversible damage.

Area of Science:

  • Pediatric Endocrinology
  • Hypertension Research
  • Steroid Biochemistry

Background:

  • Childhood hypertension diagnosis relies on plasma renin activity (PRA) and aldosterone measurements.
  • Dietary sodium balance is crucial for interpreting hormonal findings in pediatric hypertension.
  • Low-renin hypertension in children may stem from disturbances in steroid production, regulation, metabolism, or sensitivity.

Purpose of the Study:

  • To summarize the clinical features and hormonal findings of key adrenocortical disorders linked to low-renin hypertension in childhood.
  • To highlight the importance of prompt treatment initiation in pediatric hypertension to prevent irreversible hemodynamic changes.

Main Methods:

  • Review of clinical features associated with specific adrenocortical disorders.
  • Analysis of hormonal profiles, including plasma renin activity (PRA) and aldosterone levels.
  • Correlation of findings with dietary sodium balance in pediatric patients.

Main Results:

  • Identification of significant adrenocortical disorders contributing to low-renin hypertension in children.
  • Demonstration of the critical role of steroid metabolism and regulation in disease pathogenesis.
  • Emphasis on the link between hormonal imbalances and hypertension severity.

Conclusions:

  • Accurate assessment of PRA and aldosterone, alongside sodium balance, is vital for diagnosing childhood hypertension.
  • Adrenocortical disorders are significant contributors to low-renin hypertension in pediatric populations.
  • Early diagnosis and treatment are essential to mitigate long-term cardiovascular consequences.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...